Caladrius Biosciences Inc. (CLBS) Dropped -24.2% or -1.29 To Price $4.03 On Thursday


Caladrius Biosciences Inc. (CLBS) dropped -24.2% or -1.29 to $4.03. It is about 137363 shares traded, which is 638.6% compare to the average total volume 21510. The market cap of CLBS is $39.65 million. The year to date change is 6.07%. The 52 week price range is from $3.05 to $11.65. Price of CLBS have changed 1.36% during last week. It have changed 7.64% over last month, 1.56% over last 3 months, 1.96% over last 6 months and 34.97% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 4.68. It is 16.13% above current price. The 200-day Moving Averages for CLBS is 4.92. It is 22.08% above current price. The 52-week High is 11.65. It is 189.08% from the current price. The 52-week Low is 3.05. It is -24.32% from current price.

There are some statistics of CLBS. It is has market cap $39.65 million. The share outstanding is 9.84 million. The average volume is 21510. The percent of top 15 Institution holding is 10.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is -32.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is -26.81%.


Tags:

Share this post